Say Hello to Myelo
Your 24/7 AI Assistant for Myeloma Support!
Ever have a question about myeloma pop up at 3 am, leaving you frustrated and searching for answers? Now you can get the answers you need, anytime. Say hello to Myelo, your 24/7 Generative AI assistant specifically designed to support you on your myeloma journey.
Confused by medical jargon after a doctor's appointment? Myelo can translate complex terms into easy-to-understand language. Feeling overwhelmed by treatment options? Myelo can provide information on different approaches and help you navigate the next steps. Worried about how to support your loved one with myeloma? Myelo can offer suggestions for communication and teamwork within your family.
- Share
Myelo has extensive knowledge on multiple myeloma, including symptoms, diagnosis, treatment options, clinical trials, and management strategies.
In a compassionate and caring manner, Myelo addresses frequently asked questions, offers explanations on complex medical terminology, and provides guidance for patients through various stages of the disease—from diagnosis to treatment and follow-up care.
By leveraging advanced natural language processing (NLP) techniques and machine learning algorithms, Myelo can respond to queries in multiple languages. This ensures accessibility for a diverse patient population.
Myelo For Patients and Care Partners
Myelo provides an innovative avenue for patient interaction and assistance by utilizing artificial intelligence to engage with users, provide needed information, make personalized recommendations, and offer real-time support.
The chatbot navigates the IMF’s extensive web and published resources, extracts essential information, and accurately responds to a wide range of questions related to multiple myeloma in a professional yet caring tone.
Equipped with a wide range of cutting-edge features, Myelo can provide immediate answers, as well as useful source links for further information.
The IMF chatbot supplies detailed, relevant information to user questions and simplifies complex concepts into a more understandable language.
Beyond patient support, Myelo also serves as a valuable resource for healthcare providers and professionals—disseminating the latest research findings, clinical guidelines, and treatment protocols; and ensuring that physicians and medical staff remain informed about the latest developments in the field.
How to use Myelo
To start chatting with Myelo, go to www.myeloma.org and click on the blue button with the speech icon at the bottom right of the website.
A pop-up screen will appear where you can check out FAQs or type in your specific question. A transcript of the chat may also be downloaded after your queries have been answered.
While Myelo serves as a valuable resource, enhancing patient engagement and empowerment by delivering personalized information and guidance based on individual needs and preferences, keep in mind that it is an AI-powered chatbot that is not 100 percent error-free. Users are advised to exercise discretion.
The IMF’s reliable InfoLine team is always ready to help address myeloma-related questions and consistently provides callers with the best information about multiple myeloma in a caring and compassionate manner.
You may contact the IMF InfoLine by emailing [email protected] or by calling 1-800-452 CURE (2873) (U.S. and Canada), or 1 (818) 487-7455 (Worldwide).
Myelo is an AI-powered chatbot designed to act as the International Myeloma Foundation's virtual assistant for patients, care partners, and healthcare professionals.
An AI chatbot is an artificial intelligence-powered conversational agent designed to interact and communicate with humans through text interfaces. By leveraging advanced natural language processing (NLP) techniques and machine learning algorithms, Myelo can respond to queries in multiple languages. This ensures accessibility for a diverse patient population.
Myelo can answer a wide range of questions related to multiple myeloma, including symptoms, diagnosis, treatment options, clinical trials, and management strategies.
Myelo is designed to support patients, care partners, and healthcare professionals with information and resources on multiple myeloma.
The IMF developed Myelo to address the increasing demand for accessible and reliable information on multiple myeloma.
Myelo can respond to queries in multiple languages, ensuring accessibility for a diverse patient population.
You can chat with Myelo by visiting the IMF website (www.myeloma.org) and clicking on the blue button with the speech icon at the bottom right corner.
Here are some sample questions:
- "What can be done about the achy bones from Xgeva"
- "Should someone have MGUS with several family members that had MM should I be getting a bone marrow biopsy and imaging tests to see if there are different high risk bio markers?"
- "I am newly diagnosed. My FISH chromosome analysis said, 'Quantity Not Sufficient.' So, what do I do? They thought I had smoldering myeloma, but I had a few lesions (unknown) on my thoracic spine MRI. Do I repeat the bone marrow biopsy? Do I need a PET? Tissue sampling?"
While the IMF strives for accuracy, it may take time to incorporate new developments in the field of myeloma into Myelo's information.
If Myelo cannot answer your question, you can contact the IMF InfoLine for personalized assistance by emailing [email protected] or calling 1-800-452-CURE (2873) (U.S. and Canada) or 1 (818) 487-7455 (Worldwide).
No, Myelo is for informational and educational purposes only. Always consult with your doctor for medical advice.
Multiple myeloma is a cancer of the bone marrow plasma cells. It often involves damage to bone and kidneys. While incurable, significant progress has been made in terms of survival rates in recent decades.
Myelo collects information you voluntarily share during your conversation, such as the questions you ask and the answers you receive. We also collect non-personal information like your device type and IP address.
We use the information you provide to improve Myelo's functionality, personalize your experience, and generate anonymous data for research purposes.
We may share anonymized, aggregated data with research institutions or healthcare organizations for educational or scientific purposes. We may also share anonymized data with third-party software providers to improve Myelo's functionality.
Yes, you can download a transcript of your conversation by clicking the "download" button within the chatbot.
Read the International Myeloma Foundation's Privacy Policy.
Call us. We’re here for you. The InfoLine is the IMF's multiple myeloma cancer information line. The IMF’s InfoLine is here for you for your myeloma-related questions and concerns.
